Medical News Interviews
Drug-eluting stents should not be the favoured option for treating saphenous vein graft lesions according conclusions from a registry analysis presented to the American Heart Association conference by Jeff Trost from Johns Hopkins in Baltimore.
[audio:https://www.audiomedica.com/podcasting/aha2005/Jeff_Trost.mp3]
Click here for all the interviews from AHA 2005
Young adults less likely to be diagnosed with hypertension than over 60s 31 Dec, 2012 
Rapid Genotype Assay for Individualized Warfarin Dosing 25 Mar, 2007 CIBIS-3 Study: ACE Inhibitor before Beta Blocker for Congestive Heart Failure? 12 Sep, 2005 Drug-eluting Stents: Cost-Benefit Targeting? 12 Sep, 2005 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
